In the preceding three months, 9 analysts have released ratings for Ecolab ECL, presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 6 | 1 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 2 | 2 | 1 | 0 | 0 |
2M Ago | 0 | 2 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Ecolab, revealing an average target of $294.33, a high estimate of $313.00, and a low estimate of $270.00. Observing a 3.88% increase, the current average has risen from the previous average price target of $283.33.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Ecolab among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Charles Neivert | Piper Sandler | Raises | Overweight | $310.00 | $270.00 |
Joshua Spector | UBS | Raises | Neutral | $280.00 | $257.00 |
Jason Haas | Wells Fargo | Raises | Overweight | $313.00 | $295.00 |
Shlomo Rosenbaum | Stifel | Raises | Buy | $307.00 | $285.00 |
Patrick Cunningham | Citigroup | Raises | Buy | $305.00 | $290.00 |
Vincent Andrews | Morgan Stanley | Raises | Overweight | $280.00 | $263.00 |
Ashish Sabadra | RBC Capital | Lowers | Outperform | $294.00 | $306.00 |
Charles Neivert | Piper Sandler | Lowers | Overweight | $270.00 | $305.00 |
John McNulty | BMO Capital | Raises | Outperform | $290.00 | $279.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ecolab. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ecolab compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Capture valuable insights into Ecolab's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Ecolab analyst ratings.
Discovering Ecolab: A Closer Look
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.
Unraveling the Financial Story of Ecolab
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining Ecolab's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.17% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Ecolab's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.81%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Ecolab's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.47% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Ecolab's ROA excels beyond industry benchmarks, reaching 2.13%. This signifies efficient management of assets and strong financial health.
Debt Management: Ecolab's debt-to-equity ratio is below the industry average at 0.93, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyst Ratings: Simplified
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.